SL
PFE icon

Sentinus LLC’s Pfizer PFE Stock Holding History

Sentinus LLC’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$966K Buy
40,104
+4,656
+13% +$122K 0.08% 210
2026
Q1 		$995K Buy
35,448
+3,163
+10% +$84.2K 0.09% 177
2025
Q4 		$804K Buy
32,285
+19,254
+148% +$486K 0.08% 195
2025
Q3 		$332K Buy
13,031
+1,209
+10% +$29.8K 0.07% 177
2025
Q2 		$287K Buy
11,822
+121
+1% +$2.82K 0.07% 177
2025
Q1 		$297K Buy
11,701
+1,991
+21% +$52.1K 0.08% 157
2024
Q4 		$258K Sell
9,710
-3,286
-25% -$89.1K 0.08% 161
2024
Q3 		$376K Buy
12,996
+688
+6% +$20.1K 0.11% 136
2024
Q2 		$344K Buy
12,308
+3,104
+34% +$85.5K 0.11% 132
2024
Q1 		$255K Buy
+9,204
New +$255K 0.09% 148
2023
Q2 		$320K Sell
8,713
-490
-5% -$19.1K 0.1% 145
2023
Q1 		$376K Buy
+9,203
New +$397K 0.13% 122

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Sentinus LLC's PFE Position: Q2 2026 in Review

Sentinus LLC increased its Pfizer (PFE) stake by 13% in Q2 2026, buying an estimated $122K and bringing the position to 40,104 shares worth $966K. The position accounts for 0.08% of the portfolio, ranked #210.

Sentinus LLC first reported a position in PFE in Q1 2023 and has held it in 12 quarters since. The position peaked at $995K in Q1 2026. 2,832 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Sentinus LLC held 40,104 shares of Pfizer worth $966K as of Q2 2026.
  • Sentinus LLC bought 4,656 Pfizer shares in Q2 2026, an estimated $122K.
  • Pfizer made up 0.08% of Sentinus LLC's portfolio in Q2 2026, its #210 holding.
  • Sentinus LLC first reported a position in Pfizer in Q1 2023 and has held it in 12 quarters since.
  • Sentinus LLC's Pfizer position peaked at $995K in Q1 2026.
  • 2,832 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Sentinus LLC's 13F filing for Q2 2026, filed 11 Aug 2026.